Diabetes is becoming more prevalent in the UK and this is represented in the in-patient cohort, such that 1 in 6 hospital patients have diabetes
Following intervention, there was a marked improvement in management. The proportion of appropriately managed episodes increased to 82% (n=35) and management of episodes of severe hypoglycaemia (<3.0 mmol/l) increased to 94%. The time to correction increased with 40% of episodes corrected to >4.0 mmol/l within 30 minutes, and a further 54% between 30-60 minutes.
In conclusion, the introduction of 'Hypo Boxes' improved the assessment and management of hypoglycaemia.
Problem
Hypoglycaemia is a well-recognised complication in patients with diabetes mellitus on insulin or sulphonylurea therapy. It represents a significant barrier to achieving optimal glycaemic control.
Hypoglycaemia in hospital in-patients is increasingly common, mainly due to the increasing prevalence of type 2 diabetes in the UK population and a subsequent increase in the number of patients who have diabetes as a co-existing medical condition. The Joint British Diabetes Society estimate that 1 in 6 hospital in-patients will have diabetes (2) .
Hypoglycaemia has been shown to be associated with serious adverse outcomes. Specifically, it is associated with an increase in hospital mortality, as well as a longer length of hospital stay (3).
This relationship is dose dependent; both the length of stay and inpatient mortality increased as the number and/or severity of hypoglycaemic episodes increased (3) . Previous work has demonstrated a strong association with the number of episodes of hypoglycaemia following one admission, and outpatient mortality at one year (3).
The UK National Diabetes In-patient Audit in 2012 demonstrated that 20.4% of in-patients with diabetes had at least one episode of minor hypoglycaemia (3-3.9mmol/L) and 10.5% had at least one episode of severe hypoglycaemia (<3 mmol/L) (1). These episodes tend to not be treated appropriately, and patients are often given tea and toast, or biscuits, which provide an unpredictable glycaemic response and contain unnecessary saturated fats. The In-patient Audit also demonstrated that 39.8% of patients experienced at least one diabetes medication error, and these patients were twice as likely to experience a severe hypoglycaemic episode (16.8%), compared to those who did not have a medication error (1).
Hypoglycaemia in hospitalised patients with diabetes is becoming more prevalent and is associated with significant adverse outcomes. Therefore, prompt recognition and appropriate and effective management of hypoglycaemia is essential to improve patient outcomes. The Joint British Diabetes Society recommends that all hospital wards should have access to 'Hypo Boxes' to promote the correct management of these episodes (2) .
Background
There has been a huge increase in the number of people with diabetes, and it is now one of the biggest health challenges facing Page 1 of 4 the UK today. Between 1996 and 2012 the number of people diagnosed with diabetes mellitus in the UK increased from 1.4 million to 2.9 million people, and it is estimated that by 2025 there will be 5 million people with diabetes. The majority of these patients will have type 2 diabetes, which is largely due to the combination of an ageing population and the increasing numbers of overweight and obese patients (4). There may also be a delay in diagnosis of hypoglycaemia due to cognitive impairment, reduced communication, or fewer adrenergic symptoms (6).
Baseline measurement
The aim of this project was to improve the recognition and 
Strategy
The first PDSA cycle's aim was to collect data regarding episodes of hypoglycaemia, and to design an easy to use data collection tool.
This focused on the treatment provided for episodes of hypoglycaemia as well as the time to repeat blood glucose levels.
Over this 4 week period, our data collection improved so as to ensure that no episodes of hypoglycaemia were missed. The outcome of this cycle confirmed that episodes of hypoglycaemia were being inadequately managed and patients were not having repeat blood glucose testing performed in a timely manner. There also seemed to be a lack of documentation surrounding these episodes.
The second PDSA cycle involved increasing awareness of the problem throughout key ward members of staff, including awareness of the hypoglycaemia algorithm and recommended treatment options, as well as the importance of recognising and treating hypoglycaemia. We also gained approval from the wards to implement a change, and specifically agreed for the introduction of 'Hypo Boxes'. Our continued presence on the wards helped to emphasise the importance and was a continual reminder to nursing staff to assess these episodes of hypoglycaemia appropriately.
Inclusion of ward doctors also helped to further increase awareness.
The third PDSA cycle involved the introduction of 'Hypo Boxes' to the wards, along with printed copies of the hypoglycaemia algorithm. The wards were given a 2 week period to allow them to get use to the boxes and to deal with any problems that may arise before data collection restarted. The 'Hypo Boxes' contained oral glucose such as GlucoJuice, GlucoTabs and GlucoGel. The boxes were located in easily accessible places and guidance on the use of these was circulated throughout all members of ward staff. The introduction demonstrated a marked improvement in both the appropriateness of treatment given for episodes of hypoglycaemia, as well as the time to correction. More patients had repeat blood glucose levels checked to ensure resolution, and to assess the need for further treatment.
The nursing staff found the 'Hypo Boxes' easy to use, accessible, and practical. Health care assistants and members of medical staff if present, as well as nursing staff, could use the 'Hypo Box'. This improvement was sustainable over the following 4 week observation period and staff were more equipped to ensure episodes were correctly managed. The medical staff on the wards were also involved. The hope is that when they rotate jobs the new medical staff will pick up from the nursing staff the significance of the 'Hypo Boxes'. Those doctors moving on will take this knowledge and continue to promote good practice with regard to hypoglycaemia in other hospital environments.
Results
Following intervention, there was a marked improvement in both the appropriateness of management and the time to correction. In the 4 weeks following intervention, there were a similar number of episodes with 43 episodes occurring in 23 patients. This was an average of 1.8 episodes per patient (range 1-7 episodes). 10 of these patients had type 1 diabetes mellitus and 13 patients had type 2 diabetes (43% and 57% respectively). The 10 patients with type 1 diabetes were on insulin monotherapy. Of the patients with type 2 diabetes, 8 patients were on insulin therapy either as monotherapy or in combination with oral hypoglycaemic agents.
The remaining 5 patients were on combination oral hypoglycaemic therapy, and they all included a sulphonylurea. The average age was 62 years (range 34-89 years).
The number of appropriately managed episodes improved, with 82% (n=35) of episodes managed appropriately (compared to 42% pre-intervention). There were 3 episodes of hypoglycaemia with a blood glucose of 1.0-1.9 mmol/l, 11 episodes between 2.0-2.9 mmol/l and 29 episodes of hypoglycaemia with a blood glucose result 3.0-3.9 mmol/l. In the number of episodes of severe hypoglycaemia (<3.0 mmol/l), the appropriateness in management increased to 93% (n=13), with only 1 episode deemed to be treated inappropriately. The time to correction also improved with 40% of episodes being corrected within 30 minutes, and 54% corrected between 30 and 60 minutes. Overall, post-intervention 94% of episodes were corrected within 60 minutes, compared to 51% preintervention. There was 1 episode that was corrected within 90 minutes and only 2 episodes that did not have a further blood glucose repeated, which were both mild hypoglycaemic episodes between 3.5-3.9 mmol/l.
Lessons and limitations
This project emphasises the importance of involvement of all members of the multidisciplinary team to promote good clinical practice. The introduction of 'Hypo Boxes' was a simple intervention that produced significant positive results and was easy to use and readily accessible by all members of the team. We demonstrated that the use of algorithms and protocols improve our practice and can produce consistent and reproducible results, with the aim of improving patient outcomes. Education and awareness play an important role in encouraging the use of these guidelines. We would hope that with continued education and exposure to guidelines that we could achieve 100% of episodes being assessed and managed appropriately.
There is still room for improvement however, and it may be that further education and dissemination of the ongoing results to nursing and medical staff may help to promote the importance of good practice. This could include monthly run charts circulated to staff and posted in ward areas, to continue to encourage members of staff to adhere to the guidelines and strive to achieve better results. This would also aim to maintain these results and ensure that it becomes common practice.
Diabetes is becoming more prevalent and will be encountered in almost every hospital specialty. It is therefore increasingly important that this education is hospital wide and that 'Hypo Boxes' are introduced to all clinical areas and made available to every ward and department. This includes education to medical staff that rotate jobs frequently as this knowledge and skill set can be implemented in every job they encounter.
Although we demonstrated a significant improvement in results, the management of in-patients diabetes is a large problem and there are other areas that should be considered in future projects. This includes the precipitant to hypoglycaemia and changes to medications to prevent this reoccurring. Future projects should take all these factors into consideration and continue to improve the inpatient management of diabetes and any episodes of glycaemic excursion.
Conclusion
We demonstrated that the introduction of 'Hypo Boxes' to diabetes wards significantly improved the assessment and management of episodes of hypoglycaemia. The appropriateness of treatment and the time to correction improved, and ultimately this aims to improve patient outcomes, something which can be adversely affected by hypoglycaemia.
